2023
DOI: 10.1001/jamadermatol.2023.0771
|View full text |Cite
|
Sign up to set email alerts
|

Legislative Efforts Restricting Care for Transgender People

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…The second top-cited article reports the prevalence of alopecia areata in the US, establishing foundational information that will inform future studies on the topic. The third most cited article is a Viewpoint on legislative efforts restricting care for transgender patients that provides critical, timely information on how current policies may affect dermatologists and their patients.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The second top-cited article reports the prevalence of alopecia areata in the US, establishing foundational information that will inform future studies on the topic. The third most cited article is a Viewpoint on legislative efforts restricting care for transgender patients that provides critical, timely information on how current policies may affect dermatologists and their patients.…”
mentioning
confidence: 99%
“…2023 Was another exceptional year for JAMA Dermatology . The editorial team evaluated a steady number of article submissions (Table). A total of 956 of 2756 submissions were research articles.…”
mentioning
confidence: 99%
“…The Editorial titled “Legislative Efforts Restricting Care for Transgender People: Implications for Dermatologists and Patients,” published online April 26, 2023, has been updated to reflect additional legislation introduced in Louisiana and Minnesota and signed into law in Florida, Idaho, Indiana, Montana, North Dakota, and Oklahoma. This article has been corrected.…”
mentioning
confidence: 99%
“…For example, recent health-related misinformation, coupled with uncertainty during the COVID-19 pandemic, has heightened the need for high-quality, objective evidence . In the US, clinicians, policymakers, and the public have continued to deliberate about many long-standing policy issues, including the costs of health care and prescription drugs; health disparities and racial, ethnic, and gender inequities; the opioid epidemic; Medicaid and the Affordable Care Act; access to abortion and reproductive services; and clinician workforce and well-being . Controversies have also arisen over previously established standards like vaccinations and drug approvals .…”
mentioning
confidence: 99%